We provide evidence that SP-D is widely expressed in clear cell adenocarcinomas, endometrioid adenocarcinomas, mucinous adenocarcinomas, and serous adenocarcinoma. This evidence concerns the gene SFTPD and clear cell adenocarcinoma.